Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients

NCT03145480 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Investigator decision to close study

Conditions

Richter Syndrome

Interventions

DRUG: Obinutuzumab
DRUG: Ibrutinib
OTHER: CHOP

Sponsor

Northwell Health

Collaborators

[object Object]